Previous Article | Next Article 
Infection and Immunity, February 1999, p. 928-935, Vol. 67, No. 2
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Fas-FasL Interaction Involved in Pathogenesis of
Ocular Toxoplasmosis in Mice
Mark S.
Hu,1,*
Joseph D.
Schwartzman,2
Grant R.
Yeaman,3
Jane
Collins,3
Rosanne
Seguin,1
Imtiaz A.
Khan,1 and
Lloyd H.
Kasper1,3
Departments of
Medicine,1
Pathology,2 and
Microbiology,3 Dartmouth Medical
School, Lebanon, New Hampshire 03756
Received 13 July 1998/Returned for modification 28 August
1998/Accepted 5 November 1998
 |
ABSTRACT |
Ocular toxoplasmosis is a potentially blinding intraocular
inflammation. The intent of this study was to investigate the role of
Fas-FasL interaction in a murine model of acquired ocular toxoplasmosis induced by intracameral inoculation of Toxoplasma gondii.
Intraocular inflammation, Fas and FasL expression on lymphocytes
and on ocular tissues, the occurrence of apoptosis, and the frequency
of CD8+ and CD4+ T cells in the infected eyes
were analyzed in C57BL/6 (B6) mice. Susceptibility to parasite-induced
intraocular inflammation was observed in Fas-deficient
(B6-lpr) and FasL-deficient (B6-gld) mice.
Inoculation of 5,000 T. gondii tachyzoites
induced significant intraocular inflammation associated with increase
of Fas and FasL expression in the inoculated eyes of wild-type B6 mice.
Flow cytometry demonstrated a significant increase of Fas and FasL
expression on the splenocytes from naive mice incubated in vitro with
the parasite and on the splenocytes harvested from the
infected mice at day 8 after parasite inoculation. Apoptosis of
inflammatory cells and cells in ocular tissues was seen, and a greater
frequency of CD8+ than CD4+ T cells was
observed in the infected eyes. The intensity of intraocular inflammation was greater in B6-lpr and B6-gld
mice than in wild-type B6 mice (P < 0.05). The
results suggest that Fas-FasL interaction associated with apoptosis is
involved in the pathogenesis of acquired ocular toxoplasmosis in mice.
 |
INTRODUCTION |
Human infection with
Toxoplasma gondii, an intracellular parasite, is ubiquitous
(18). Although benign in most individuals, infection with
T. gondii causes significant disease in two groups, newborns and the immunosuppressed, in particular those with AIDS. The
parasite is also a frequent cause of potentially blinding ocular
disease (27, 31). Ocular toxoplasmosis causes a necrotizing retinitis or retinochoroiditis (1, 11, 15), which is
reportedly immune mediated (28). Although most cases of
human eye infection are believed to be congenital in origin, acquired
acute toxoplasmic retinochoroiditis may be more prevalent than is now
recognized (23, 31, 32). Ocular toxoplasmosis may be a
component or the presenting manifestation of human
immunodeficiency virus infection or AIDS (29). At present
there is no consensus for the best initial treatment for this eye
disorder because of the poorly understood pathogenesis (15,
32).
Fas (APO1/CD95) and its ligand (FasL, CD95 ligand) are type I and type
II transmembrane proteins and members of the tumor necrosis
factor/nerve growth factor receptor and tumor necrosis factor families
of proteins, respectively (5, 22, 37). Fas is ubiquitously
expressed on lymphoid and nonlymphoid cells, while FasL is restricted
to T cells and some nonlymphoid tissues, known to be immune privileged
sites, including the eye (10, 24). The roles of these
molecules in the regulation of immunity and autoimmune disease have
been extensively studied in lpr (for lymphoproliferation)
and gld (for general lymphoproliferative disease) mice,
which carry autosomal recessive mutations and consequently lack
functional expression of Fas and FasL (24, 30). Fas and FasL
interaction is closely associated with immune privilege and probably
provides a barrier to prevent the interaction of Fas+
inflammatory cells and pathogens from damaging tissues in privileged sites or tissues (10, 24). Recent studies in a herpes
simplex virus-induced model of ocular inflammation demonstrated that
the Fas-FasL interaction protected the infected eye from the spread of
dangerous inflammatory responses (9). We therefore
hypothesized that Fas-FasL interaction, as a protective mechanism
against infection by the protozoan parasite T. gondii,
may be involved in pathophysiological process of the parasite-induced
ocular inflammation.
Mice have been shown to be suitable for studying the pathogenesis of
this infection (7). A novel murine model of acquired ocular
toxoplasmosis was recently developed in our laboratory by intracameral
inoculation of strain PLK tachyzoites (12). In this study,
we describe the involvement of Fas-FasL interaction in the
parasite-induced ocular inflammation in mice.
 |
MATERIALS AND METHODS |
Parasite.
T. gondii PLK was used throughout these
experiments. This clone of Me49 was produced and is maintained in our
laboratory by continuous passage in human fibroblasts in Eagle's
minimum essential medium (MEM; Gibco Laboratories, Grand Island, N.Y.)
supplemented with 10% newborn calf serum plus antibiotics. Parasites
used in these studies were obtained from tissue culture in human
fibroblast cells at passage <50. All parasite challenge experiments
were performed with tissue culture-derived tachyzoites at various
inoculum levels.
Animals.
Female C57BL/6 (B6), B6-lpr, and
B6-gld mice, 6 to 8 weeks of age, were obtained from Jackson
Laboratory (Bar Harbor, Maine). For each strain, 10 of each group were
used in each experiment. These mice were bred under approved conditions
in the Animal Research Facility at Dartmouth Medical School. Control
mice of the same parental lineage were age and sex matched.
Intraocular inoculation of parasites.
The mice were
intracamerally challenged as previously described in a
herpesvirus-induced model of ocular inflammation in mice (12,
35). Mice were anesthetized intraperitoneally with 0.08 ml of a
1:1 mixture of ketamine hydrochloride (Mallinckrodt Veterinary, Inc.,
Mundelein, Ill.) and xylazine (Phoenix Pharmaceutical, Inc., St.
Joseph, Mo.) diluted 1:1 with sterile water. Mice were then placed
under the operating microscope, and anterior chamber paracentesis was
performed by puncturing the cornea midway between the limbus and
central cornea on the right eye, using a glass micropipette. After
leaking aqueous humor was blotted, 5 µl of parasite suspension containing 5,000 tachyzoites in MEM was injected into the anterior chamber via a 33-gauge needle attached to a 50-µl Hamilton syringe. In some experiments, 5 µl of MEM was inoculated into the
contralateral eye or into eyes of additional mice to exclude injection
trauma as a cause of inflammatory reaction.
Clinical observation.
Eyes of all mice were examined under
the operating microscope every day following intracameral challenge
with T. gondii for conjunctival congestion, corneal
edema, pupillary dilatation, iris vessel prominence, anterior chamber
clouding, cataract, retinal opacification, loss of red reflex, and
scleral reaction. Mice were also monitored for evidence of systemic
infection such as behavior, fur ruffling, and moribund status. The
presence of inflammation was scored on a scale of 0 (normal) to
5+ as follows: 1+, apparent ciliary congestion
around the cornea; 2+, intense ciliary congestion with
slight cornea edema and anterior chamber clouding; 3+,
obvious intraocular inflammatory reaction such as iris vessel prominence, vitreous, and retinal opacification; 4+,
endophthalmitis; 5+, obvious ophthalmia with systemic
symptoms and/or death in addition to 4+ ocular
inflammation. The final score included findings from histopathological observation.
Histopathology.
At day 8 after parasite challenge, eyes were
enucleated after mice were sacrificed by CO2 inhalation and
were preserved in 10% buffered formalin. Fixed eyes were embedded in
paraffin, serially sectioned at 5 µm, and stained with hematoxylin
and eosin. The pathological changes were scored on a scale of 0 (normal) to 5+, similar to the clinical scores: 0, normal
histology; 1+, vessel dilation, protein precipitate, and
<20 inflammatory cells in anterior chamber and vitreous humor per
single section; 2+, obvious inflammatory reaction (more
than 20 but fewer than 50 inflammatory cells in the ocular cavity) in
the anterior segment and few focal lesions of the inner retina;
3+, >50 inflammatory cells in the anterior chamber and
vitreous humor, with moderate necrotic retinitis, uveitis, keratitis,
vitreitis, and cataract formation; 4+, intensive
retinouveitis or endophthalmitis; 5+, features of the
preceding classes with extraocular inflammation including scleritis,
conjunctivitis, and blepharitis.
Flow cytometry analysis for Fas and FasL on splenocytes.
To
evaluate the influence of T. gondii on Fas and FasL
expression, normal splenocytes were isolated and incubated in vitro with T. gondii tachyzoites (splenocyte/parasite ratio
of 2:1) for 48 h. Fresh splenocytes of infected mice that had been
inoculated intraocularly with 5,000 tachyzoites were isolated from the
spleens harvested at day 8 postinfection. The splenocytes were stained with antibodies to CD95 (Jo2) and to CD95L (Kay-10) (PharMingen, San
Diego, Calif.) and analyzed by flow cytometry as previously described
(20). Normal splenocytes were stained as the control, and
the isotype antibodies hamster immunoglobulin G (IgG) and mouse IgG2b
were used for staining as controls to CD95 and CD95L, respectively.
Fas and FasL detection by immunohistostaining.
The eyes were
harvested at day 8 from mice given 5,000 intraocular tachyzoites and
were frozen immediately. Immunohistochemistry on frozen sections were
carried out with monoclonal antibodies to Fas (N-18) and to FasL (N-20)
(Santa Cruz Biotechnology Inc., Santa Cruz, Calif.) as specified by the
manufacturer. Briefly, the sections were exposed at room temperature
for 30 min and fixed in cold acetone. Endogenous peroxidase activity
was quenched in 0.8% hydrogen peroxide, and nonspecific binding was
blocked with 1.5% normal goat serum in phosphate-buffered saline (PBS;
pH 7.4). Sections were incubated with antibodies to either Fas or FasL at room temperature for 30 min and then incubated with
biotin-conjugated second antibodies. After a series of three washes in
PBS and a rinse in 1% Triton X-100-PBS, the sections were incubated
in diaminobenzidine solution for 2 min for visible color and
counterstained in hematoxylin for contrast.
Detection of apoptosis.
By using a terminal
deoxynucleotidyltransferase (TdT) in situ apoptosis detection kit with
TACS blue label (Genzyme Diagnostics, Cambridge, Mass.), TdT-mediated
dUTP-biotin nick end labeling (TUNEL) (2) was applied to the
paraffin-embedded sections of the injected eyes of B6 mice for direct
detection of apoptosis according to the manufacturer's protocol.
Briefly, ocular tissues (harvested at 48 h, 96 h, and 8 days
after intraocular infection) on slides were deparaffinized at 57°C
for 5 min on a slide warmer and then washed three times, once each in
100, 95, and 70% ethanol. Samples were permeabilized with proteinase K
(1:50) for 5 min at room temperature, and endogenous peroxidase was
quenched in a solution of 2% H2O2. TdT
labeling was carried out with the TdT enzyme (1:50) in 1× labeling
buffer in the humidity chamber at 37°C for 1 h, followed by
detection of TACS blue label for 6 min. After washing with deionized
water, counterstaining was performed with Red counterstain C solution
for 30 s. Normal B6 eyes were used as controls, and HL-60, ML-1,
and WI-L2 cell lines supplied by the manufacturer were used as positive
and negative controls of apoptosis.
Determination of CD8+ and CD4+ T cells in
the eye.
The frequency of CD8+ and CD4+ T
cells in the eye at day 8 postinfection was determined by
immunophenotyping as described previously (38). Briefly, 30- to 70-µm sections of fresh enucleated eye were cut with a vibratome
(V1000; Technical Products International Inc., St. Louis, Mo.).
Fluorescein isothiocyanate-conjugated antibodies (L3T4 for CD4, Ly2 for
CD8, and rat IgG2a
as controls; 2 µg/100 µl; PharMingen) in PBS
were added to sections, which were then incubated overnight at 4°C in
the dark. Stained sections were visualized in a Bio-Rad MR1000 confocal
scanning laser microscope system equipped with a krypton-argon laser.
Using this system, we were able to optically section the specimens and
build three-dimensional reconstructions of the tissue sections. This
allowed accurate determination of the specific relationships among
cells. Using Image Space software (Molecular Dynamics), we counted cell
numbers in three dimensions (within an area of 240.5 by 240.5 µm) and derived semiquantitative estimations of staining intensities.
Statistical analysis.
Clinical observation, pathological
evaluation, and determination of T cells in the eyes by confocal
scanning were carried out in a double-blind manner by at least two
investigators. Variations were expressed as standard errors of the
mean, and statistical comparisons between groups were performed by
Student's t test. P values less than 0.05 were
considered statistically significant.
 |
RESULTS |
Ocular inflammatory reaction of wild-type B6 mice.
All mice
receiving 5,000 parasites developed significant ocular inflammation at
day 6 or 7. Inflammation progressed with time as described previously
(12). The inflammation score was 3.3 ± 0.7 (n = 10 [Fig. 1 and
2]). Histopathologic analysis was
consistent with clinical observation. Intraocular inflammation was
obvious (Fig. 3B) and characterized as
predominantly mononuclear inflammatory infiltration, accompanied by
necrotic retinitis or uveoretinitis.

View larger version (121K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Uninfected eye; (B to D) ocular inflammation at day
8 of B6 mice (B) and significantly more intensively inflammatory
reaction of the eyes of B6-lpr (C) and B6-gld (D)
mice intraocularly infected with 5,000 tachyzoites. (Magnification,
×20.)
|
|
Ocular inflammation in B6-lpr and B6-gld
mice.
Mice with Fas or FasL mutations differed from the parental
strain with respect to the induction and severity of the inflammation. The mutant mice were more susceptible than wild-type B6 mice to the
parasites. Both Fas and FasL mutant mice that received 5,000 parasites
had increased local ocular inflammation, and half exhibited ophthalmia.
Obvious systemic reactions such as fur ruffling and/or moribund status
were observed in all mice at day 8 postinoculation. The inflammation
scores at day 8 after inoculation were 4.1 ± 0.4 (n = 10) and 4.0 ± 0.3 (n = 10) for the
B6-lpr and B6-gld mice, respectively. The
inflammatory reaction was significantly more severe than that of the
wild-type B6 mice (P < 0.05). The inflammation was
first noted at day 4 or 5 in the injected eyes of B6-lpr or
B6-gld mice (Fig. 1 and 2). Histopathologically, the
inflammation was intense and associated with tissue destruction. The
cornea became thickened, consisting of a large number of inflammatory cells and neovascularization. The anterior chamber was filled with
inflammatory cells and protein, accompanied by necrotic iridocyclitis and cataract formation in all mice. In the posterior segment, necrotic
retinitis and uveitis were seen, with striking involvement of vitreous
humor and sclera (Fig. 3C and D).
Increased expression of Fas and FasL in infected eyes and
splenocytes.
Immunohistostaining showed that normal B6 mouse
retina expressed Fas (Fig. 4A) as well as
FasL (Fig. 4C), which had been previously demonstrated in mice by
Griffith et al. (9, 10). The observation is consistent with
the report that Fas and FasL are expressed constitutively in normal
human retina (2). The inflamed parasite-inoculated eyes
harvested at day 8 postinfection showed a striking increase of both Fas
(Fig. 4B) and FasL (Fig. 4D) expression.

View larger version (159K):
[in this window]
[in a new window]
|
FIG. 4.
Fas (A) and FasL (C) expression on normal B6 mouse
retina (arrows) and strikingly increased Fas (B) and FasL (D)
expression on inflammatory retina of the infected eye at day 8 after
intraocular infection with 5,000 parasites. R, retina; U, uvea; V,
vitreous humor. (Magnification, ×120.)
|
|
Analysis by flow cytometry showed that
T. gondii
enhanced expression of Fas and FasL on normal B6 mouse splenocytes
incubated
with the PLK strain of the parasite (2:1) for 48 h (Fig.
5a and
b). Fas and FasL expression on
splenocytes of B6 mice infected
intraocularly with
T. gondii PLK was also notably increased (Fig.
5c and d).

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 5.
Compared with the control isotype antibodies (light
line), increased expression (bold line) of Fas and FasL on normal B6
mouse splenocytes incubated for 48 h with T. gondii PLK (2:1) (a and b) and on infected B6 mouse splenocytes
and harvested at day 8 after intraocular inoculation with 5,000 tachyzoites (c and d).
|
|
Apoptosis in the eye.
There was no evidence of apoptosis in
the normal control B6 eyes (Fig. 6A and
B). Apoptosis of
infiltrating cells was observed in the anterior chamber 48 h (Fig.
6C) and in the vitreous humor of the injected eyes of the B6 mice
96 h (Fig. 6D) after intraocular infection. These apoptotic
changes were demonstrated as well in ocular tissues such as the lens
(Fig. 6E) and retina (Fig. 6F), associated with intraocular
inflammation at day 8 after infection. In comparison to wild-type B6
mice, B6-lpr and B6-gld mice demonstrated much
less apoptosis (Fig. 6G and H) of the infiltrating cells and tissues of
the T. gondii-infected eyes.

View larger version (96K):
[in this window]
[in a new window]
|
FIG. 6.
No apoptosis was detected in the anterior chamber and
vitreous humor and in tissues such as the cornea, lens and retina of
the eye (A and B). Apoptosis (dark blue) of infiltrating cells was seen
in the anterior chamber of B6 mice at 48 h (C) and in the vitreous
humor at day 4 (D), and apoptotic cells in the lens (E) and retina (F)
were detected at day 8 after intraocular inoculation of 5,000 parasites. There were fewer apoptotic cells in the eyes of either
B6-lpr (G) or B6-gld (H) mice at day 4 after
infection. Ac, anterior chamber; C, cornea; Cb, ciliary body; L, lens;
R, retina; U, uvea; V, vitreous humor. (Magnification, ×200.)
|
|
Frequency of CD8+ and CD4+ T cells in
infected eyes.
Both CD8+ (Fig.
7A) and CD4+ (Fig. 7B) T
cells were evident, with a predominance of CD8+ T cells in
the infected eyes at day 8.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 7.
CD8+ and CD4+ T cells in
infected eyes at day 8. A greater frequency of CD8+ (A)
than of CD4+ (B) T cells was observed at day 8. (Magnification, ×40.)
|
|
 |
DISCUSSION |
Ocular toxoplasmosis causes destructive intraocular inflammation
targeting the retina and uvea and potentially resulting in blindness
(15, 27, 32). Intracameral inoculation of tachyzoites of
T. gondii PLK induced ocular inflammation, as we have
previously reported (12). Histopathologic analysis of the
ocular lesions demonstrated predominantly mononuclear cell infiltration
and tissue necrosis within the eye, which resembles features of ocular
toxoplasmosis in humans. Using this in vivo model, we have demonstrated
that Fas and FasL expression is enhanced on splenocytes as
well as in tissues of the eye, accompanied by apoptosis which occurred in early through late stage in this study. Meanwhile, earlier and more
severe intraocular inflammation was observed in both B6-lpr and B6-gld mice that lack Fas or FasL
compared to parental B6 mice. The results indicate that the Fas-FasL
system is involved in the process of parasite-induced ocular
inflammation and that apoptosis is associated with the
inflammatory reaction in the eye.
The possibility that Fas-FasL interaction plays a role in protection of
the eye was suggested by study of a murine model of herpesvirus-induced
ocular inflammation (9). Herpesvirus induces uveoretinitis
and keratitis which are mediated mainly by CD4+ T cells
(16, 26). In our murine model, T. gondii-induced host response and intraocular inflammation are
mediated predominantly by CD8+ T cells, as shown in this
and a previous (17) study. On the other hand, herpesvirus is
a documented inducer of apoptosis (34), while the role of
T. gondii in the apoptotic process remains unresolved (20, 21, 25). To clarify the role of Fas-FasL in the process of ocular toxoplasmosis, we have shown for the first time that enhanced
Fas-FasL expression was indeed involved and apoptosis occurred in
T. gondii-infected eyes.
It is of interest that Fas and FasL expression is significantly
increased not only on host splenocytes incubated in vitro with the
parasite but also on splenocytes harvested from the intraocularly infected mice. The results are consistent with observations
demonstrating induction of Fas on lymphocytes by in vitro coculture
with T. gondii tachyzoites (13). Further,
Fas and FasL were expressed in the normal mouse eyes, and the level of
expression was significantly enhanced upon parasite infection. It is
speculated that the increase in Fas and FasL expression of the infected
eye could be due directly to parasites, and the increased expression of
the apoptotic marker in splenocytes of the infected mice might be
elicited directly by the organisms that have migrated to the spleen
from the inoculated eye. Details of the mechanisms by which the
parasite enhances the expression of Fas and FasL in the eye and how the
parasites inoculated in the eye influence the expression of apoptotic
molecules on the splenocytes remain to be elucidated.
Our results suggest that a decrease in either Fas or FasL expression
may lead to rapid development of severe and destructive ocular
inflammation. We hypothesize that apoptosis induced by Fas-FasL
interaction may play a role in protection in the anterior chamber in
early events after the inoculation of parasites. It is suggested that
mice with deficient Fas-FasL function have a decreased capability to
limit parasite replication so that inflammation is more intense and
destructive than in the parental mice with normal Fas-FasL expression.
Apoptosis is an important mechanism for protection against virus
infection in the eye (9, 33). The potential role of T. gondii in apoptotic processes is not entirely
understood. Protozoan parasite activation-induced
CD4+ T-cell apoptosis has been demonstrated
during acute T. gondii infection in mice
(20). Gamma interferon-induced, Fas-dependent apoptosis of
Peyer's patch T cells in mice follows peroral infection with
T. gondii (21), while T. gondii-infected cells demonstrate resistance to multiple inducers
of apoptosis (25). The present study of ocular
toxoplasmosis is supportive of the notion that T. gondii can evoke apoptosis. Apoptosis, in contrast to necrosis, characteristically does not elicit an inflammatory response, thereby allowing an organism to safely eliminate unnecessary or potentially harmful cells (36). It seems, however, that enhanced
Fas-FasL expression and possible Fas-FasL-induced apoptosis may
play dual roles during active toxoplasma replication in the eye. In the early stage apoptosis may be protective, helping to eliminate the
relatively small number of tachyzoites. In contrast, overproduction of
Fas-FasL is invoked in the pathogenesis of a number of diseases, such
as hepatitis, thyroiditis, and uveitis (2, 6). Apoptosis in
the retina observed in the late stage of ocular toxoplasmosis may be
the result of increased expression of Fas and FasL and may contribute
to ocular tissue damage.
An imbalance between the protective and destructive effects of the host
immune response in the pathogenesis of ocular toxoplasmosis has been
suggested (3). The control of systemic infection is dependent on a strong cell-mediated immune response (4, 14). There is abundant evidence for the crucial role of CD8+ T
cells in systemic immunity to this pathogen (4, 14, 19). CD4+ T cells appear to synergize with CD8+ T
cells to afford protection against T. gondii
(8). Whether these T-cell subsets act in the eye as they do
in the systemic infection remains to be illustrated. Further studies
are under way to identify in detail the mechanisms by which Fas and/or
FasL expression may interact with CD8+ and/or
CD4+ T cells and the phenotype of the apoptotic cells that
we observed in ocular tissues.
 |
ACKNOWLEDGMENTS |
This work was supported by NIH grants AI19613 and K32AI1558.
We thank Karlya Wheeler for assistance with the ocular
histopathological sections.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: 644E Borwell
Research Building, Department of Medicine, Dartmouth Medical School,
One Medical Center Dr., Lebanon, NH 03756. Phone: (603) 650-8384. Fax:
(603) 650-6841. E-mail: Mark.S.Hu{at}Dartmouth.EDU.
Editor:
R. N. Moore
 |
REFERENCES |
| 1.
|
Berger, B. B.,
C. E. Egwuagu,
W. R. Freeman, and C. A. Wiley.
1993.
Miliary toxoplasmic retinitis in acquired immunodeficiency syndrome.
Arch. Ophthalmol.
111:373-376[Abstract/Free Full Text].
|
| 2.
|
Chan, C. C.,
D. M. Matteson,
Q. Li,
S. M. Whitcup, and R. B. Nussenblatt.
1997.
Apoptosis in patients with posterior uveitis.
Arch. Ophthalmol.
115:1559-1567[Abstract/Free Full Text].
|
| 3.
|
Decoster, A.,
F. Darcy, and A. Capron.
1988.
Recognition of T. gondii excreted and secreted antigens by human sera from acquired and congenital toxoplasmosis: identification of markers of acute and chronic infection.
Clin. Exp. Immunol.
73:376[Medline].
|
| 4.
|
Denkers, E. Y.,
A. Sher, and R. T. Gazzinelli.
1993.
CD8+ T-cell interactions with T. gondii: implications for processing of antigen for class-I-restricted recognition.
Res. Immunol.
144:51-57[Medline].
|
| 5.
|
Depraetere, V., and P. Golstein.
1997.
Fas and other cell death signaling pathways.
Semin. Immunol.
9:93-107[Medline].
|
| 6.
|
French, L. E., and J. Tschopp.
1997.
Thyroiditis and hepatitis: Fas on the road to disease.
Nat. Med.
3:387-388[Medline].
|
| 7.
|
Gazzinelli, R. T.,
A. Brezin,
Q. Li,
R. B. Nussenblatt, and C. C. Chan.
1994.
Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF- and IFN- .
Exp. Parasitol.
78:217-229[Medline].
|
| 8.
|
Gazzinelli, R. T.,
F. T. Hakim,
S. Hieny,
G. M. Shearer, and A. Sher.
1991.
Synergistic role of CD4+ and CD8+ T lymphocytes in IFN- production and protective immunity induced by an attenuated T. gondii vaccine.
J. Immunol.
146:286-292[Abstract].
|
| 9.
|
Griffith, T. S.,
T. Brunner,
S. M. Fletcher,
D. R. Green, and T. A. Ferguson.
1995.
Fas ligand-induced apoptosis as a mechanism of immune privilege.
Science
270:1189-1192[Abstract/Free Full Text].
|
| 10.
|
Griffith, T. S., and T. A. Ferguson.
1997.
The role of FasL-induced apoptosis in immune privilege.
Immunol. Today
18:240-244[Medline].
|
| 11.
|
Holland, G. H.,
G. R. O'Connor,
R. F. Diaz,
P. Minasi, and W. M. Wara.
1988.
Ocular toxoplasmosis in immunosuppressed nonhuman primates.
Investig. Ophthalmol. Vis. Sci.
29:835-842[Abstract/Free Full Text].
|
| 12.
|
Hu, M. S.,
J. Schwartzman,
J. Y. Channon,
I. A. Khan, and L. H. Kasper.
1998.
A novel murine model of acute ocular toxoplasmosis by intracameral inoculation.
Investig. Ophthalmol. Vis. Sci.
39:S782. (Abstr. 3618.)
|
| 13.
|
Hundt, M., and R. E. Schmidt.
1997.
Induction of Fas/APO-1 (CD95) on lymphocytes co-culture with T. gondii tachyzoites.
Immunol. Lett.
56:213.
|
| 14.
|
Innes, E. A.,
W. R. Panton,
A. Sanderson,
K. M. Thomson,
J. M. Wastling,
S. Maley, and D. Buxton.
1995.
Induction of CD4+ and CD8+ T cell responses in efferent lymph responding to Toxoplasma gondii infection: analysis of phenotype and function.
Parasitol. Immunol.
17:151-160[Medline].
|
| 15.
|
Jabs, D. A., and P. Quinlan.
1994.
Ocular toxoplasmosis, p. 1531-1543.
In
S. J. Ryan, A. P. Schachat, and R. B. Murphy (ed.), Retina. C. V. Mosby, St. Louis, Mo.
|
| 16.
|
Jayaraman, S.,
A. Heiligenhaus,
A. Rodriguez,
S. Soukiasian,
M. E. Dorf, and C. S. Foster.
1993.
Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells.
J. Immunol.
151:5777-5789[Abstract].
|
| 17.
|
Kasper, L. H.,
I. A. Khan,
K. H. Ely,
R. Buelow, and J. C. Boothroyd.
1992.
Antigen-specific (p30) mouse CD8+ T cells are cytotoxic against T. gondii-infected peritoneal macrophages.
J. Immunol.
148:1493-1498[Abstract].
|
| 18.
|
Kasper, L. H.,
J. C. Boothroyd,
K. Warren, and N. Agabian.
1993.
Toxoplasma gondii, p. 269-298.
In
K. Warren, and N. Agabian (ed.), Immunology and molecular biology of parasitic diseases. Blackwell Scientific, Boston, Mass.
|
| 19.
|
Khan, I. A.,
K. H. Ely, and L. H. Kasper.
1991.
A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal T. gondii infection in mice.
J. Immunol.
147:3501-3506[Abstract].
|
| 20.
|
Khan, I. A.,
T. Matsuura, and L. H. Kasper.
1996.
Activation-mediated CD4+ T cell unresponsiveness during acute T. gondii infection in mice.
Int. Immunol.
8:887-896[Abstract/Free Full Text].
|
| 21.
|
Liesenfeld, O.,
J. C. Kosek, and Y. Suzuki.
1997.
Gamma interferon induces Fas-dependent apoptosis of Peyer's patch T cells in mice following peroral infection with Toxoplasma gondii.
Infect. Immun.
65:4682-4689[Abstract].
|
| 22.
|
Memon, S. A.,
J. Hou,
M. B. Moreno, and C. M. Zacharchuk.
1998.
Cutting edge: apoptosis induced by a chimeric Fas/FLICE receptor: lack of requirement for Fas- or FADD-binding proteins.
J. Immunol.
160:2046-2049[Abstract/Free Full Text].
|
| 23.
|
Montoya, J. C., and J. S. Remington.
1996.
Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis.
Clin. Infect. Dis.
23:277-282[Medline].
|
| 24.
|
Nagata, S., and P. Golstein.
1995.
The Fas death factor.
Science
267:1449-1456[Abstract/Free Full Text].
|
| 25.
|
Nash, P. B.,
M. B. Purner,
R. P. Leon,
P. Clarke,
R. C. Duke, and T. J. Curiel.
1998.
T. gondii-infected cells are resistant to multiple inducers of apoptosis.
J. Immunol.
160:1824-1830[Abstract/Free Full Text].
|
| 26.
|
Niemialtowski, M. G., and B. T. Rouse.
1992.
Phenotypic and functional studies on ocular T cells during herpetic infections of the eye.
J. Immunol.
148:1864-1870[Abstract].
|
| 27.
|
Nussenblatt, R. B., and A. G. Palestine.
1989.
Ocular toxoplasmosis, p. 336-354.
In
R. B. Nussenblatt, and A. G. Palestine (ed.), Uveitis. Year Book Medical Publisher, Inc., St. Louis, Mo.
|
| 28.
|
Nussenblatt, R. B.,
K. K. Mittal,
S. Fuhrman,
S. D. Sharma, and A. G. Palestine.
1989.
Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens.
Am. J. Ophthalmol.
107:632-641[Medline].
|
| 29.
|
Pomeroy, C.,
R. Noble,
M. McCormick, and B. Young.
1996.
Ocular toxoplasmosis as the presenting manifestation of human immunodeficiency virus infection.
Clin. Infect. Dis.
24:745-746.
|
| 30.
|
Sabelko, K. A.,
K. A. Kelly,
M. H. Nahm,
A. H. Cross, and J. H. Russell.
1997.
Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system.
J. Immunol.
159:3096-3099[Abstract].
|
| 31.
|
Silveira, C.,
R. Belfort,
M. Burnier, and R. B. Nussenblatt.
1988.
Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families.
Am. J. Ophthalmol.
106:362-364[Medline].
|
| 32.
|
Stanford, M.
1996.
Acute symptomatic Toxoplasma retinochoroiditis.
Eye
10:3-4.
|
| 33.
|
Streilein, J. W.
1995.
Unraveling immune privilege.
Science
270:1158-1159[Abstract/Free Full Text].
|
| 34.
|
Thompson, C. B.
1995.
Apoptosis in the pathogenesis and treatment of disease.
Science
267:1456-1462[Abstract/Free Full Text].
|
| 35.
|
Whittum, J. A.,
J. P. McCulley,
J. Y. Niederkorn, and J. W. Streilein.
1984.
Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus.
Investig. Ophthalmol. Vis. Sci.
25:1065-1073[Abstract/Free Full Text].
|
| 36.
|
Wong, B.,
C. G. Park, and Y. Choi.
1997.
Identifying the molecular control of T-cell death; on the hunt for killer genes.
Semin. Immunol.
9:7-16[Medline].
|
| 37.
|
Wu, M. X.,
Z. Ao,
M. Hegen,
C. Morimoto, and S. F. Schlossman.
1996.
Requirement of Fas (CD95), CD45, and CD11 /CD18 in monocyte-dependent apoptosis of human T cells.
J. Immunol.
157:707-713[Abstract].
|
| 38.
|
Yeaman, R. G.,
P. M. Guyre,
M. W. Fanger,
J. E. Collins,
H. D. White,
W. Rathbn,
K. A. Orndorff,
J. Gonzalez,
J. E. Stern, and C. R. Wira.
1997.
Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium.
J. Leukoc. Biol.
61:427-435[Abstract].
|
Infection and Immunity, February 1999, p. 928-935, Vol. 67, No. 2
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hippe, D., Lytovchenko, O., Schmitz, I., Luder, C. G. K.
(2008). Fas/CD95-Mediated Apoptosis of Type II Cells Is Blocked by Toxoplasma gondii Primarily via Interference with the Mitochondrial Amplification Loop. Infect. Immun.
76: 2905-2912
[Abstract]
[Full Text]
-
Charles, E., Callegan, M. C., Blader, I. J.
(2007). The SAG1 Toxoplasma gondii Surface Protein Is Not Required for Acute Ocular Toxoplasmosis in Mice. Infect. Immun.
75: 2079-2083
[Abstract]
[Full Text]
-
Collins, C., Wolfe, J., Roessner, K., Shi, C., Sigal, L. H., Budd, R. C.
(2005). Lyme Arthritis Synovial {gamma}{delta} T Cells Instruct Dendritic Cells via Fas Ligand. J. Immunol.
175: 5656-5665
[Abstract]
[Full Text]
-
Barreiro, R., Luker, G., Herndon, J., Ferguson, T. A.
(2004). Termination of Antigen-Specific Immunity by CD95 Ligand (Fas Ligand) and IL-10. J. Immunol.
173: 1519-1525
[Abstract]
[Full Text]
-
Norose, K., Mun, H.-S., Aosai, F., Chen, M., Piao, L.-X., Kobayashi, M., Iwakura, Y., Yano, A.
(2003). IFN-{gamma}-Regulated Toxoplasma gondii Distribution and Load in the Murine Eye. IOVS
44: 4375-4381
[Abstract]
[Full Text]
-
Davies, M. H., Eubanks, J. P., Powers, M. R.
(2003). Increased Retinal Neovascularization in Fas Ligand-Deficient Mice. IOVS
44: 3202-3210
[Abstract]
[Full Text]
-
Gavrilescu, L. C., Denkers, E. Y.
(2003). Interleukin-12 p40- and Fas Ligand-Dependent Apoptotic Pathways Involving STAT-1 Phosphorylation Are Triggered during Infection with a Virulent Strain of Toxoplasma gondii. Infect. Immun.
71: 2577-2583
[Abstract]
[Full Text]
-
Shen, D. F., Matteson, D. M., Tuaillon, N., Suedekum, B. K., Buggage, R. R., Chan, C.-C.
(2001). Involvement of Apoptosis and Interferon-{gamma} in Murine Toxoplasmosis. IOVS
42: 2031-2036
[Abstract]
[Full Text]
-
Gavrilescu, L. C., Denkers, E. Y.
(2001). IFN-{{gamma}} Overproduction and High Level Apoptosis Are Associated with High but Not Low Virulence Toxoplasma gondii Infection. J. Immunol.
167: 902-909
[Abstract]
[Full Text]